Clinical Trial Update: Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial results evaluate sitagliptin for HIV-associated insulin resistance and inflammation. The results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• HIV Infection

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Inflammation, Macrophage Infiltration | Phase 3 | Status: COMPLETED | Results posted: 2015-03-05